BioCentury | Nov 3, 2011
Distillery Therapeutics

Indication: Autoimmune disease

...jseddon@tuftsmedicalcenter.org Contact: Soumya Raychaudhuri, Brigham and Women's Hospital, Boston, Mass. e-mail: soumya@broadinstitute.org Retinitis; ophthalmic disease Guanylate cyclase activator 1A retina (GUCA1A)...
...help treat retinitis pigmentosa (RP). In a transgenic mouse model of RP expressing mutant bovine Guca1a...
...scrambled control shRNA. Planned work includes testing an AAV vector delivering shRNA against mutant mouse Guca1a...
BioCentury | Nov 3, 2011
Distillery Therapeutics

Indication: Ophthalmic disease

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Ophthalmic disease Retinitis; ophthalmic disease Guanylate cyclase activator 1A retina (GUCA1A) Mouse...
...help treat retinitis pigmentosa (RP). In a transgenic mouse model of RP expressing mutant bovine Guca1a...
...scrambled control shRNA. Planned work includes testing an AAV vector delivering shRNA against mutant mouse Guca1a...
Items per page:
1 - 2 of 2